Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.20.2
Summary of Significant Accounting Policies (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
Dec. 31, 2019
USD ($)
Jun. 30, 2020
USD ($)
test
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
segment
Jun. 30, 2019
USD ($)
Summary of Significant Accounting Policies [Line Items]            
Total test volume (as a percent)     28.10%      
Total revenues     $ 301,207 $ 226,368 $ 512,674 $ 448,820
Provision for inventory obsolescence         1,700 1,300
Goodwill, in-process research and development and other intangible assets acquired $ 1,800,000 $ 1,800,000 1,800,000   1,800,000  
Goodwill 671,599 671,940 671,599   671,599  
Net intangible assets other than goodwill 1,100,000 1,100,000 1,100,000   1,100,000  
Amortization expense     14,937 16,419 29,874 32,981
Depreciation expense         14,400 14,500
Allowance for doubtful accounts receivable $ (1,573) $ (1,934) (1,573)   (1,573)  
Provision related to current period sales         200 200
Equity-based compensation expense         $ 4,000 7,600
Number of reportable segments | segment         2  
CMS Accelerated and Advanced Payment Program, COVID-19            
Summary of Significant Accounting Policies [Line Items]            
Proceeds from issuance of debt     14,000      
Distribution to Healthcare Providers, COVID-19            
Summary of Significant Accounting Policies [Line Items]            
Proceeds from issuance of debt     6,200      
Transfer of intellectual property and other            
Summary of Significant Accounting Policies [Line Items]            
Total revenues     20,880 $ 19,230 $ 30,433 $ 37,490
Transfer of intellectual property and other | Distribution to Healthcare Providers, COVID-19            
Summary of Significant Accounting Policies [Line Items]            
Total revenues     $ 6,200   $ 6,200  
Diagnostics            
Summary of Significant Accounting Policies [Line Items]            
Change in testing volume (as a percent)     (46.50%)      
Serology Antibody Test            
Summary of Significant Accounting Policies [Line Items]            
Number of tests performed | test     331,600      
Tests performed per day | test     400,000      
Diagnostic Molecular Test            
Summary of Significant Accounting Policies [Line Items]            
Number of tests performed | test     2,200,000      
Tests performed per day | test     50,000      
Minimum            
Summary of Significant Accounting Policies [Line Items]            
Intangible assets, estimated useful lives         3 years  
Maximum            
Summary of Significant Accounting Policies [Line Items]            
Intangible assets, estimated useful lives         20 years  
Government Contracts Concentration Risk | Accounts Receivable            
Summary of Significant Accounting Policies [Line Items]            
Concentration percentage 11.00% 6.00%        
Geographic Concentration Risk | Accounts Receivable            
Summary of Significant Accounting Policies [Line Items]            
Concentration percentage 37.60%          
Customer Concentration Risk | Accounts Receivable            
Summary of Significant Accounting Policies [Line Items]            
Concentration percentage 2.00% 2.50%        
Software            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives         3 years  
Machinery, Medical and Other Equipment | Minimum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives         5 years  
Machinery, Medical and Other Equipment | Maximum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives         8 years  
Furniture and Fixtures | Minimum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives         5 years  
Furniture and Fixtures | Maximum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives         12 years  
Buildings and Improvements | Minimum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives         10 years  
Buildings and Improvements | Maximum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives         40 years  
Automobiles and Aircraft | Minimum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives         3 years  
Automobiles and Aircraft | Maximum            
Summary of Significant Accounting Policies [Line Items]            
Property, plant and equipment, estimated useful lives         5 years  
In Process Research and Development            
Summary of Significant Accounting Policies [Line Items]            
Net intangible assets other than goodwill $ 590,200 $ 590,200 $ 590,200   $ 590,200